Cosciens Biopharma Files Routine 6-K
Ticker: CSCIF · Form: 6-K · Filed: Apr 2, 2025 · CIK: 1113423
Sentiment: neutral
Topics: reporting, compliance, foreign-private-issuer
TL;DR
Cosciens Biopharma filed a 6-K, nothing major, just keeping the SEC updated.
AI Summary
Cosciens Biopharma Inc. filed a Form 6-K on April 2, 2025, reporting for the month of April 2025. The company, formerly known as Aeterna Zentaris Inc., is a foreign private issuer. The filing does not contain specific financial figures or operational updates but serves as a routine disclosure.
Why It Matters
This filing indicates ongoing compliance and reporting by Cosciens Biopharma Inc. as a foreign private issuer, which is standard for companies listed on US exchanges.
Risk Assessment
Risk Level: low — This is a routine administrative filing (6-K) with no new material financial or operational information, thus posing minimal immediate risk.
Key Numbers
- 001-38064 — SEC File Number (Identifies the company's filing with the SEC)
Key Players & Entities
- COSCIENS Biopharma Inc. (company) — Filer
- Aeterna Zentaris Inc. (company) — Former company name
- Norton Rose Fulbright Canada, LLP (company) — Legal counsel/address provider
- 001-38064 (dollar_amount) — SEC File Number
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers that is required to be filed with the SEC to provide information that the issuer makes or is required to make public pursuant to the laws of its home country, or that it furnishes or is required to furnish to its security holders.
When was Cosciens Biopharma Inc. formerly known as?
Cosciens Biopharma Inc. was formerly known as Aeterna Zentaris Inc.
What is the SIC code for Cosciens Biopharma Inc.?
The Standard Industrial Classification (SIC) code for Cosciens Biopharma Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Where is the principal executive office of Cosciens Biopharma Inc. located?
The principal executive office is located at c/o Norton Rose Fulbright Canada, LLP, 222 Bay Street, Suite 3000, PO Box 53, Toronto ON M5K 1E7.
Does Cosciens Biopharma Inc. file annual reports under Form 20-F or 40-F?
Cosciens Biopharma Inc. indicates that it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 2, 2025 regarding COSCIENS Biopharma Inc. (CSCIF).